ArticlePharmaceutics2022

Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine.

Kristopher K Short et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.